The continual rise in sulfadoxine (SDX) resistance affects the therapeutic efficacy of sulfadoxine-pyrimethamine; therefore, careful monitoring will help guide its prolonged usage. Mutations in dihydropteroate synthase (dhps) are being surveilled, based on their link with SDX resistance. However, there is a lack of continuous analyses and data on the potential effect of molecular markers on the dhps structure and function.
View Article and Find Full Text PDFThe rational search for allosteric modulators and the allosteric mechanisms of these modulators in the presence of mutations is a relatively unexplored field. Here, we established novel approaches and applied them to SARS-CoV-2 main protease (M) as a case study. First, we identified six potential allosteric modulators.
View Article and Find Full Text PDFBackground: Plasmodial transketolase (PTKT) enzyme is one of the novel pharmacological targets being explored as potential anti-malarial drug target due to its functional role and low sequence identity to the human enzyme. Despite this, features contributing to such have not been exploited for anti-malarial drug design. Additionally, there are no anti-malarial drugs targeting PTKTs whereas the broad activity of these inhibitors against PTKTs from other Plasmodium spp.
View Article and Find Full Text PDFPyrazinamide (PZA) is the only first-line antitubercular drug active against latent (). It is activated to pyrazinoic acid by the -encoded pyrazinamidase enzyme (PZase). Despite the emergence of PZA drug resistance, the underlying mechanisms of resistance remain unclear.
View Article and Find Full Text PDF